Introduction: Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic disorders that are more likely to progress to acute myeloid leukemia (AML). Alogenic Haematopoietic Stem Cell Transplantation (HSCT) represents the most effective curative treatment for MDS to date. Objectives: To describe the profile of patients with MDS, who performed HSCT at the Walter Cantídio Universitary Hospit...